Michael Minogue maintains a commanding lead in the Massachusetts Republican gubernatorial primary scheduled for September 1, 2026, driven by his strong polling advantage among likely GOP voters and key endorsements following Mike Kennealy’s elimination at the state convention. As a former Abiomed CEO with business credentials and party support, Minogue has consolidated backing in a low-profile race where opponents like Brian Shortsleeve, a former MBTA administrator, trail significantly. Recent surveys showing Minogue ahead by roughly two-to-one margins have reinforced trader consensus on his nomination path. A surprise upset remains possible only through unusually high turnout for lesser-known challengers or unforeseen late developments in the final days before voting.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedMichael Minogue 97.2%
Brian Shortsleeve 2.0%
Mike Kennealy <1%
$41,460 Vol.
$41,460 Vol.

Michael Minogue
97%

Brian Shortsleeve
2%

Mike Kennealy
1%
Michael Minogue 97.2%
Brian Shortsleeve 2.0%
Mike Kennealy <1%
$41,460 Vol.
$41,460 Vol.

Michael Minogue
97%

Brian Shortsleeve
2%

Mike Kennealy
1%
If no 2026 Massachusetts Gubernatorial Republican Primary takes place, this market will resolve to “Other.”
The resolution source for this market will be the first official announcement of the results from the Massachusetts Republican Party; however, an overwhelming consensus of credible reporting may suffice.
Market Opened: Dec 10, 2025, 4:20 PM ET
Resolver
0x2F5e3684c...If no 2026 Massachusetts Gubernatorial Republican Primary takes place, this market will resolve to “Other.”
The resolution source for this market will be the first official announcement of the results from the Massachusetts Republican Party; however, an overwhelming consensus of credible reporting may suffice.
Resolver
0x2F5e3684c...Michael Minogue maintains a commanding lead in the Massachusetts Republican gubernatorial primary scheduled for September 1, 2026, driven by his strong polling advantage among likely GOP voters and key endorsements following Mike Kennealy’s elimination at the state convention. As a former Abiomed CEO with business credentials and party support, Minogue has consolidated backing in a low-profile race where opponents like Brian Shortsleeve, a former MBTA administrator, trail significantly. Recent surveys showing Minogue ahead by roughly two-to-one margins have reinforced trader consensus on his nomination path. A surprise upset remains possible only through unusually high turnout for lesser-known challengers or unforeseen late developments in the final days before voting.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions